Cardiovascular disease (CVD) is the leading cause of death worldwide. Although advances in pharmaceuticals, surgical procedures, and implant technologies have reduced mortality rates, CVD continues to burden the healthcare system; in 2021-2022, $14.3B of the Australian healthcare budget was attributed to CVD[1].Continue Reading
MEMKO was proud to actively contribute to the 15th Australian Flight Test Symposium (AFTS), hosted by the Test and Evaluation (T&E) Directorate of the Royal Australian Air Force at the University of Newcastle.Continue Reading
